Blocking TNF-α signaling by using an anti-TNF-α monoclonal antibody (143), pentoxifylline (144), etanercept (145), or infliximab (146) significantly alleviated intestinal inflammation and tissue damage in NEC neonatal rats. This evidence concerns the gene TNF and necrotizing enterocolitis.